NGENF (NervGen Pharma) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. NervGen Pharma's Free Cash Flow for the three months ended in Sep. 2024 was $-4.25 Mil. NervGen Pharma's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, NervGen Pharma's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, NervGen Pharma's current FCF Yield % is -8.90%.

The historical rank and industry rank for NervGen Pharma's FCF Margin % or its related term are showing as below:

NGENF's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -145.32
* Ranked among companies with meaningful FCF Margin % only.

NervGen Pharma FCF Margin % Historical Data

The historical data trend for NervGen Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NervGen Pharma FCF Margin % Chart

NervGen Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

NervGen Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of NervGen Pharma's FCF Margin %

For the Biotechnology subindustry, NervGen Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NervGen Pharma's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NervGen Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where NervGen Pharma's FCF Margin % falls into.

NervGen Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

NervGen Pharma's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-8.525	/	0
	=	%

NervGen Pharma's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-4.247	/	0
	=	%

NervGen Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of NervGen Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

NervGen Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (OTCPK:NGENF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

9UA:Germany NGEN:Canada

Address

112-970 Burrard Street, Unit 1290, Vancouver, BC, CAN, V6Z 2R4

Website

https://www.nervgen.com

NervGen Pharma Corp principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291, and NVG-300.

NervGen Pharma Headlines

From GuruFocus

NervGen Pharma To Webcast At VirtualInvestorConferences.com July 11th

By PRNewswire PRNewswire • 07-09-2019